Moleculin Biotech, Inc. Increase (Decrease) in Prepaid Expense
Moleculin Biotech, Inc. (MBRX) reported Increase (Decrease) in Prepaid Expense of $653.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidExpense · last filed 2026-08-13
- Moleculin Biotech, Inc. increase (decrease) in prepaid expense for the quarter ending 2026-06-30 was $816.00K, a 2.64% increase year-over-year.
- Moleculin Biotech, Inc. increase (decrease) in prepaid expense for the quarter ending 2026-03-31 was -$163.00K, a 123.02% decline year-over-year.
- Moleculin Biotech, Inc. increase (decrease) in prepaid expense for the quarter ending 2025-12-31 was -$374.00K.
- Moleculin Biotech, Inc. increase (decrease) in prepaid expense for the quarter ending 2025-09-30 was -$337.00K.
- Moleculin Biotech, Inc. increase (decrease) in prepaid expense for fiscal 2025 was $792.00K.
- Moleculin Biotech, Inc. increase (decrease) in prepaid expense for fiscal 2024 was -$1.81M, a 764.34% decline from fiscal 2023.
- Moleculin Biotech, Inc. increase (decrease) in prepaid expense for fiscal 2023 was $272.00K, a 68.26% decline from fiscal 2022.
- Moleculin Biotech, Inc. increase (decrease) in prepaid expense for fiscal 2022 was $857.00K.
| Period end | Increase (Decrease) in Prepaid Expense 2 month | Increase (Decrease) in Prepaid Expense 3 month | Increase (Decrease) in Prepaid Expense 6 month | Increase (Decrease) in Prepaid Expense 6 month as first filed | Increase (Decrease) in Prepaid Expense 9 month | Increase (Decrease) in Prepaid Expense 9 month as first filed | Increase (Decrease) in Prepaid Expense 12 month | Increase (Decrease) in Prepaid Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $816.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $653.00K 10-Q · filed 2026-08-13 | $279.00K derived: sum of 3 quarters · filed 2026-08-13 | -$58.00K derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2026-03-31 | -$163.00K 10-Q · filed 2026-05-14 | -$537.00K derived: sum of 2 quarters · filed 2026-05-14 | -$874.00K derived: sum of 3 quarters · filed 2026-05-14 | -$79.00K derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-12-31 | -$374.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | -$711.00K derived: sum of 2 quarters · filed 2026-03-18 | $84.00K derived: sum of 3 quarters · filed 2026-08-13 | $792.00K 10-K · filed 2026-03-18 | ||||
| 2025-09-30 | -$337.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $458.00K derived: sum of 2 quarters · filed 2026-08-13 | $1.17M 10-Q · filed 2025-11-13 | -$119.00K derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-06-30 | $795.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $1.50M 10-Q · filed 2026-08-13 | $218.00K derived: sum of 3 quarters · filed 2026-08-13 | -$467.00K derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-03-31 | $708.00K 10-Q · filed 2026-05-14 | -$577.00K derived: sum of 2 quarters · filed 2026-05-14 | -$1.26M derived: sum of 3 quarters · filed 2026-05-14 | -$509.00K derived: sum of 4 quarters · filed 2026-05-14 | ||||
| 2024-12-31 | -$1.28M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | -$1.97M derived: sum of 2 quarters · filed 2026-03-18 | -$1.22M derived: sum of 3 quarters · filed 2026-03-18 | -$1.81M 10-K · filed 2026-03-18 | ||||
| 2024-09-30 | -$685.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $68.00K derived: sum of 2 quarters · filed 2025-11-13 | -$522.00K 10-Q · filed 2025-11-13 | -$823.00K derived: sum of 4 quarters · filed 2025-11-13 | ||||
| 2024-06-30 | $753.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | $163.00K 10-Q · filed 2025-08-12 | -$138.00K derived: sum of 3 quarters · filed 2025-08-12 | -$322.00K derived: sum of 4 quarters · filed 2025-08-12 | ||||
| 2024-03-31 | -$590.00K 10-Q · filed 2025-05-13 | -$891.00K derived: sum of 2 quarters · filed 2025-05-13 | -$1.07M derived: sum of 3 quarters · filed 2025-05-13 | $109.00K derived: sum of 4 quarters · filed 2025-05-13 | ||||
| 2023-12-31 | -$301.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-21 | -$485.00K derived: sum of 2 quarters · filed 2025-03-21 | $699.00K derived: sum of 3 quarters · filed 2025-03-21 | $272.00K 10-K · filed 2025-03-21 | ||||
| 2023-09-30 | -$184.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | $1.00M derived: sum of 2 quarters · filed 2024-11-08 | $573.00K 10-Q · filed 2024-11-08 | -$77.00K derived: sum of 4 quarters · filed 2024-11-08 | ||||
| 2023-06-30 | $1.18M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | $757.00K 10-Q · filed 2024-08-13 | $107.00K derived: sum of 3 quarters · filed 2024-08-13 | -$115.00K derived: sum of 4 quarters · filed 2024-08-13 | ||||
| 2023-03-31 | -$427.00K 10-Q · filed 2024-05-10 | -$1.08M derived: sum of 2 quarters · filed 2024-05-10 | -$1.30M derived: sum of 3 quarters · filed 2024-05-10 | $868.00K derived: sum of 4 quarters · filed 2024-05-10 | ||||
| 2022-12-31 | -$650.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-22 | -$872.00K derived: sum of 2 quarters · filed 2024-03-22 | $1.29M derived: sum of 3 quarters · filed 2024-03-22 | $857.00K 10-K · filed 2024-03-22 | ||||
| 2022-09-30 | -$222.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $1.95M derived: sum of 2 quarters · filed 2023-11-13 | $1.51M 10-Q · filed 2023-11-13 | $1.21M derived: sum of 4 quarters · filed 2023-11-13 | ||||
| 2022-06-30 | $2.17M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $1.73M 10-Q · filed 2023-08-10 | $1.43M derived: sum of 3 quarters · filed 2023-08-10 | $993.00K derived: sum of 4 quarters · filed 2023-08-10 | ||||
| 2022-03-31 | -$438.00K 10-Q · filed 2023-05-10 | -$736.00K derived: sum of 2 quarters · filed 2023-05-10 | -$1.17M derived: sum of 3 quarters · filed 2023-05-10 | -$570.00K derived: sum of 4 quarters · filed 2023-05-10 | ||||
| 2021-12-31 | -$298.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-22 | -$736.00K derived: sum of 2 quarters · filed 2023-03-22 | -$132.00K derived: sum of 3 quarters · filed 2023-03-22 | -$431.00K 10-K · filed 2023-03-22 | ||||
| 2021-09-30 | -$438.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $166.00K derived: sum of 2 quarters · filed 2022-11-10 | -$133.00K 10-Q · filed 2022-11-10 | -$563.00K derived: sum of 4 quarters · filed 2022-11-10 | ||||
| 2021-06-30 | $604.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | $305.00K 10-Q · filed 2022-08-12 | -$125.00K derived: sum of 3 quarters · filed 2022-08-12 | -$685.00K derived: sum of 4 quarters · filed 2022-08-12 | ||||
| 2021-03-31 | -$299.00K 10-Q · filed 2022-05-11 | -$729.00K derived: sum of 2 quarters · filed 2022-05-11 | -$1.29M derived: sum of 3 quarters · filed 2022-05-11 | -$412.00K derived: sum of 4 quarters · filed 2022-05-11 | ||||
| 2020-12-31 | -$430.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-24 | -$990.00K derived: sum of 2 quarters · filed 2022-03-24 | -$113.00K derived: sum of 3 quarters · filed 2022-03-24 | -$724.00K 10-K · filed 2022-03-24 | ||||
| 2020-09-30 | -$560.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $317.00K derived: sum of 2 quarters · filed 2021-11-10 | -$294.00K 10-Q · filed 2021-11-10 | -$722.00K derived: sum of 4 quarters · filed 2021-11-10 | ||||
| 2020-06-30 | $877.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-11 | $266.00K 10-Q · filed 2021-08-11 | -$162.00K derived: sum of 3 quarters · filed 2021-08-11 | $1.51M derived: sum of 4 quarters · filed 2021-08-11 | ||||
| 2020-03-31 | -$611.00K 10-Q · filed 2021-05-12 | -$1.04M derived: sum of 2 quarters · filed 2021-05-12 | $631.00K derived: sum of 3 quarters · filed 2021-05-12 | $1.31M derived: sum of 4 quarters · filed 2021-05-12 | ||||
| 2019-12-31 | -$428.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-24 | $1.24M derived: sum of 2 quarters · filed 2021-03-24 | $1.92M derived: sum of 3 quarters · filed 2021-03-24 | $1.91M 10-K · filed 2021-03-24 | ||||
| 2019-09-30 | $1.67M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | $2.35M derived: sum of 2 quarters · filed 2020-11-12 | $2.34M 10-Q · filed 2020-11-12 | $2.42M derived: sum of 4 quarters · filed 2020-11-12 | ||||
| 2019-06-30 | $676.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-12 | $667.00K 10-Q · filed 2020-08-12 | $747.00K derived: sum of 3 quarters · filed 2020-08-12 | $337.00K derived: sum of 4 quarters · filed 2020-08-12 | ||||
| 2019-03-31 | -$9.00K 10-Q · filed 2020-05-11 | $71.00K derived: sum of 2 quarters · filed 2020-05-11 | -$339.00K derived: sum of 3 quarters · filed 2020-05-11 | $197.00K derived: sum of 4 quarters · filed 2020-05-11 | ||||
| 2018-12-31 | $80.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-19 | -$330.00K derived: sum of 2 quarters · filed 2020-03-19 | $206.00K derived: sum of 3 quarters · filed 2020-03-19 | $252.00K 10-K · filed 2020-03-19 | ||||
| 2018-09-30 | -$410.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $126.00K derived: sum of 2 quarters · filed 2019-11-12 | $172.00K 10-Q · filed 2019-11-12 | $18.00K derived: sum of 4 quarters · filed 2019-11-12 | ||||
| 2018-06-30 | $536.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-16 | $582.00K 10-Q · filed 2019-08-16 | $428.00K derived: sum of 3 quarters · filed 2019-08-16 | $351.00K derived: sum of 4 quarters · filed 2019-08-16 | ||||
| 2018-03-31 | $46.00K 10-Q · filed 2019-05-13 | -$108.00K derived: sum of 2 quarters · filed 2019-05-13 | -$185.00K derived: sum of 3 quarters · filed 2019-05-13 | $355.00K derived: sum of 4 quarters · filed 2019-05-13 | ||||
| 2017-12-31 | -$154.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-21 | -$231.00K derived: sum of 2 quarters · filed 2019-02-21 | $309.00K derived: sum of 3 quarters · filed 2019-02-21 | $364.00K 10-K · filed 2019-02-21 | ||||
| 2017-09-30 | -$77.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13 | $463.00K derived: sum of 2 quarters · filed 2018-11-13 | $518.00K 10-Q · filed 2018-11-13 | $488.00K derived: sum of 4 quarters · filed 2018-11-13 | ||||
| 2017-06-30 | $540.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-10 | $595.00K 10-Q · filed 2018-08-10 | $565.00K derived: sum of 3 quarters · filed 2018-08-10 | $495.00K derived: sum of 4 quarters · filed 2018-08-10 | ||||
| 2017-03-31 | $55.00K 10-Q · filed 2018-05-14 | $25.00K derived: sum of 2 quarters · filed 2018-05-14 | -$45.00K derived: sum of 3 quarters · filed 2018-05-14 | $270.00K derived: sum of 4 quarters · filed 2018-05-14 | ||||
| 2016-12-31 | -$30.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-28 | -$100.00K derived: sum of 2 quarters · filed 2018-03-28 | $215.00K derived: sum of 3 quarters · filed 2018-03-28 | $215.00K 10-K · filed 2018-03-28 | $215.05K 10-K · filed 2017-04-03 | |||
| 2016-09-30 | -$70.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-13 | $245.00K derived: sum of 2 quarters · filed 2017-11-13 | $245.00K 10-Q · filed 2017-11-13 | $244.87K 10-Q · filed 2016-11-21 | ||||
| 2016-06-30 | $315.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-11 | $315.00K 10-Q · filed 2017-08-11 | $315.14K 10-Q · filed 2016-08-15 | |||||
| 2016-03-31 | $0.00 10-Q · filed 2017-05-12 | |||||||
| 2015-09-30 | $23.00K 10-Q · filed 2016-11-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |